The Supreme Court’s decision Thursday not to impose restrictions on a key abortion drug, while a victory for abortion rights advocates, crystallizes the stakes of the next presidential election for access nationwide. Because a president has enormous power to influence federal agencies that oversee abortion policy, a potential Trump administration could unilaterally choose to do what the Supreme Court did not: impose strict restrictions on mifepristone, one of two drugs used in over 60 percent of abortions — or even move to take the drug off the market entirely. “This decision means the ball is squarely in the next administration’s court,” said Roger Severino, who oversees abortion policy at the conservative Heritage Foundation and led abortion-related initiatives in the Department of Health and Human Services under Trump. “It’s up to the next administration to restore some semblance of safety to this largely unregulated regime of chemical abortion.”https://www.washingtonpost.com/politics/2024/06/13/abortion-pill-biden-trump-election/

Source: Washington Post June 14, 2024 00:45 UTC